-
Pooled Phase 2/3 Data on Delgocitinib Illustrate Consistent Safety Profile in CHE
18 Sep 2025 23:02 GMT
… of nearly a half dozen phase 2 and phase 3 trials of … from the US Food and Drug Administration in July 2025.1 … safety data pooled from five clinical trials remains consistent with previously established …
-
Formation Bio Expands Leadership Team With Top Biotech and Pharma Executives to Accelerate AI-Driven Drug Development
18 Sep 2025 18:37 GMT
… AI-native pharmaceutical company revolutionizing drug development, today announced the … and advancing a pipeline of Phase 2 and 3 assets. Earlier in … identify promising drug candidates, optimize program design, and streamline clinical trials. The goal …
-
Deep Dive: Oral Obesity Drugs on the Cusp
18 Sep 2025 13:08 GMT
… drugs
Novo Nordisk
Viking Therapeutics
Lead asset: VK2735
Stage: Phase II … : TERN-601
Stage: Phase II
Readout: Q4 2025
Rhythm … Lead asset: Bivamelagon
Stage: Phase II
Readout: July 2025
The … s weekly newsletter covering clinical trial results and research news …
-
Eribulin plus Pyrotinib in Trastuzumab-Resistant, HER2-Positive Advanced Breast Cancer: A Single-Arm, Multicenter Phase II Trial (EPIC Trial)
17 Sep 2025 17:44 GMT
… exceeding 18 months in clinical trials.2,3 Despite this … T-DXd), an antibody-drug conjugate linking trastuzumab to … evidence is limited to Phase II clinical trial data, necessitating further validation … a single-arm, multicenter Phase 2 trial. BMC Med. 2023; …
-
Bio Protocol Raises $6.9M To Launch AI-Native Decentralized Science Platform For Biotech Funding & Drug Discovery
18 Sep 2025 08:51 GMT
… , scientific funding and drug discovery.
A Platform … rapidly advancing toward clinical trials at a fraction … – longevity program progressing toward Phase 2 clinical trials in the UAE.
VitaRNA … funding, Bio accelerates drug discovery, reduces costs …
-
Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agonist-induced Weight Loss by Preserving Lean Mass, Presented at EASD
17 Sep 2025 13:30 GMT
… analyses from the ongoing Phase 2 COURAGE trial investigating … discovery and accelerates drug development using our … s Product Candidates in clinical trials; determinations by regulatory … of product candidates to clinical trials, therapeutic applications, or …
-
NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy
17 Sep 2025 13:00 GMT
… and following confirmation of Clinical Trial Authorisation (CTA) by the … of the NVG-222 clinical trial application represents a … Phase 1, or early Phase 2 clinical trials. https://www … production of both Drug Substances (DS) and Drug Products (DP). …
-
Elicio Therapeutics Reports ELI-002 7P Achieved Robust mKRAS-Specific T Cell Responses in 99% of Evaluable Patients in Ongoing Phase 2 AMPLIFY-7P Trial
17 Sep 2025 12:00 GMT
… survival analysis of the Phase 2 AMPLIFY-7P clinical trial; the potential of Elicio … ’s clinical trials, including the final disease-free survival analysis from the Phase 2 … any planned investigational new drug application or new drug application; Elicio’s …
-
AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P)
17 Sep 2025 12:00 GMT
… double-blind, surgically controlled Phase 2 clinical trial evaluating the safety and … statements regarding AskBio’s clinical trials. These forward-looking … States Food and Drug Administration or the … randomized in AskBio Phase II gene therapy trial for …
-
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
17 Sep 2025 11:00 GMT
… 1: 1) Planning adaptive Phase 2/3 study Approximately 70 … ) concomitantly with MAO inhibitors drugs. During the acute recovery … may occur. Other serotonergic drugs: Serotonin syndrome has been … -treated patients in the clinical trials in adult patients with …
About
© 1995-2025